LIST OF BINDING INTERFACES for query 'RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4' in category 'PROTEIN NAME'

(Click on the 'Details' column to view details on interfaces and similar patterns of amino acids)
Click on the 'View' column to view patterns on the structural viewer)
PDB Ligand Drug Indication Macromolecule/
Organism
Pfam Binding_Interfaces (View) Details
3bbt FMMLapatinib
(DB01259)
Lapatinib is an antineoplastic agent and tyrosine kinase inhibitor used for the treatment of advanced or metastatic HER-negative breast cancer in patients who received prior chemotherapeutic treatments.RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4
(Homo sapiens)
PK_Tyr_Ser-Thr
PDB Ligand Drug Indication Macromolecule/
Organism
Pfam Binding_Interfaces (View) Details